Antithymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: matched analysis within the Korean multicentric registry

• Hauptverfasser: Jun Young Lee (Verfasst von), Sung Hwa Kim (Verfasst von), Yeon Ho Park (Verfasst von), Jae Berm Park (Verfasst von), Su Hyung Lee (Verfasst von), Jaeseok Yang (Verfasst von), Myoung Soo Kim (Verfasst von), Deok Gie Kim (Verfasst von)
• Format: Buch
• Veröffentlicht: The Korean Society of Nephrology, 2022-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background Basiliximab (BSX) and antithymocyte globulins (ATGs), are two major immunosuppressive agents commonly used as induction therapy for kidney transplant (KT) recipients. The superiority of ATG over BSX has not been well established, especially in elderly KT recipients with low immunological...